| Ticker | Current Price | % Daily Change | Volume (1,000s) | Average Volumn (1,000s) | Market Cap (Millions) | 1/2/2024 Price | % Change Since Inception 1/2/2024 |
|---|---|---|---|---|---|---|---|
| ALGS | $41.15 | -5.119% | 462 | 376 | $143 | $0.71 | 5,700.7% |
Aligos Therapeutics, Inc.
One Corporate Drive
2nd Floor
South San Francisco, CA 94080
United States
Aligos is a biopharmaceutical company developing targeted therapeutics to address unmet medical needs in liver and viral diseases including MASH, CHB and COVID-19.